HOTH
Price
$1.50
Change
-$0.08 (-5.06%)
Updated
Jan 17 closing price
Capitalization
10.36M
PPTDF
Price
$17.85
Change
+$0.70 (+4.08%)
Updated
Dec 26 closing price
Capitalization
1.76B
Ad is loading...

HOTH vs PPTDF

Header iconHOTH vs PPTDF Comparison
Open Charts HOTH vs PPTDFBanner chart's image
Hoth Therapeutics
Price$1.50
Change-$0.08 (-5.06%)
Volume$876.99K
Capitalization10.36M
Peptidream
Price$17.85
Change+$0.70 (+4.08%)
Volume$1.4K
Capitalization1.76B
HOTH vs PPTDF Comparison Chart
Loading...
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOTH vs. PPTDF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOTH is a Hold and PPTDF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (HOTH: $1.50 vs. PPTDF: $17.85)
Brand notoriety: HOTH and PPTDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOTH: 7% vs. PPTDF: 57%
Market capitalization -- HOTH: $10.36M vs. PPTDF: $1.76B
HOTH [@Biotechnology] is valued at $10.36M. PPTDF’s [@Biotechnology] market capitalization is $1.76B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOTH’s FA Score shows that 1 FA rating(s) are green whilePPTDF’s FA Score has 1 green FA rating(s).

  • HOTH’s FA Score: 1 green, 4 red.
  • PPTDF’s FA Score: 1 green, 4 red.
According to our system of comparison, both HOTH and PPTDF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOTH’s TA Score shows that 6 TA indicator(s) are bullish while PPTDF’s TA Score has 0 bullish TA indicator(s).

  • HOTH’s TA Score: 6 bullish, 4 bearish.
  • PPTDF’s TA Score: 0 bullish, 2 bearish.
According to our system of comparison, HOTH is a better buy in the short-term than PPTDF.

Price Growth

HOTH (@Biotechnology) experienced а -21.05% price change this week, while PPTDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

HOTH is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PPTDF($1.76B) has a higher market cap than HOTH($10.4M). HOTH YTD gains are higher at: 100.508 vs. PPTDF (0.000). PPTDF has higher annual earnings (EBITDA): 34.8B vs. HOTH (-7.53M). PPTDF has more cash in the bank: 25.5B vs. HOTH (8.02M). HOTH has less debt than PPTDF: HOTH (33.8K) vs PPTDF (20.9B). PPTDF has higher revenues than HOTH: PPTDF (55.4B) vs HOTH (0).
HOTHPPTDFHOTH / PPTDF
Capitalization10.4M1.76B1%
EBITDA-7.53M34.8B-0%
Gain YTD100.5080.000-
P/E RatioN/A21.03-
Revenue055.4B-
Total Cash8.02M25.5B0%
Total Debt33.8K20.9B0%
FUNDAMENTALS RATINGS
HOTH vs PPTDF: Fundamental Ratings
HOTH
PPTDF
OUTLOOK RATING
1..100
9650
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9821
PRICE GROWTH RATING
1..100
3539
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOTH's Valuation (25) in the Pharmaceuticals Major industry is somewhat better than the same rating for PPTDF (90) in the null industry. This means that HOTH’s stock grew somewhat faster than PPTDF’s over the last 12 months.

HOTH's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as PPTDF (100) in the null industry. This means that HOTH’s stock grew similarly to PPTDF’s over the last 12 months.

PPTDF's SMR Rating (21) in the null industry is significantly better than the same rating for HOTH (98) in the Pharmaceuticals Major industry. This means that PPTDF’s stock grew significantly faster than HOTH’s over the last 12 months.

HOTH's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as PPTDF (39) in the null industry. This means that HOTH’s stock grew similarly to PPTDF’s over the last 12 months.

PPTDF's P/E Growth Rating (98) in the null industry is in the same range as HOTH (100) in the Pharmaceuticals Major industry. This means that PPTDF’s stock grew similarly to HOTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOTHPPTDF
RSI
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 11 days ago
74%
Bearish Trend 11 days ago
38%
Momentum
ODDS (%)
Bullish Trend 11 days ago
87%
N/A
MACD
ODDS (%)
Bullish Trend 11 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 11 days ago
33%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
37%
Advances
ODDS (%)
Bullish Trend 12 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
67%
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
HOTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WIREX19.710.34
+1.76%
Wireless
LEGCX50.340.53
+1.06%
Columbia Large Cap Growth C
PSSMX27.210.14
+0.52%
Principal SmallCap S&P 600 Index R3
IEGAX19.280.04
+0.21%
Invesco EQV Intl Small Company A
BLRYX11.13N/A
N/A
Brookfield Global Listed Real Estate I

HOTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOTH has been loosely correlated with TIL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HOTH jumps, then TIL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOTH
1D Price
Change %
HOTH100%
-5.06%
TIL - HOTH
34%
Loosely correlated
-2.10%
PPTDF - HOTH
32%
Poorly correlated
N/A
CRMD - HOTH
31%
Poorly correlated
-4.85%
AIM - HOTH
30%
Poorly correlated
+8.42%
OGEN - HOTH
28%
Poorly correlated
-5.37%
More

PPTDF and

Correlation & Price change

A.I.dvisor tells us that PPTDF and HOTH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PPTDF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PPTDF
1D Price
Change %
PPTDF100%
N/A
HOTH - PPTDF
31%
Poorly correlated
-5.06%
CYCC - PPTDF
28%
Poorly correlated
+0.99%
IGC - PPTDF
22%
Poorly correlated
N/A
LABFF - PPTDF
22%
Poorly correlated
N/A
CPMV - PPTDF
21%
Poorly correlated
N/A
More